The Vice Presidents at Immatics are key leaders responsible for overseeing various strategic and operational functions critical to advancing the company's mission in cancer immunotherapy. They lead departments in target and T cell receptor research, clinical development, regulatory affairs, quality operations, business development, and more, ensuring alignment with corporate goals and the successful development and commercialization of innovative cancer treatment solutions.
Ali Mohamed
VP, CMC
Andrea Mayer
Vice President, Global Head of...
Claudia Blattner
Vice President Business Develo...
Claudia Wagner
Vice President TCR Research
Dominik Maurer
VP, Immunology & Site Head Tue...
Ephraim Hofsäß
Vice President SEC Reporting &...
Kerry Sieger
Vice President Global Quality ...
Miriam Meyer
Vice President Global Head of ...
Oliver Schoor
VP, Target Research
Sarah Missel
Vice President Development Lea...
View all